查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1775545

全球数位病理学市场预测（2025-2030）

Digital Pathology Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球数位病理学市场预计将从 2025 年的 1,078,255,000 美元成长到 2030 年的 2,305,011,000 美元，复合年增长率为 16.41%。

本研究报告对全球数位病理学市场进行了全面分析，为行业专业人士提供了关于塑造这一变革性医疗保健行业的市场趋势、技术进步和竞争策略的关键见解。报告探讨了关键的市场动态，包括市场驱动因素、限制因素和机会，并按产品类型、最终用户、应用和地区进行了详细细分。我们对数位病理学市场的研究旨在支援策略决策，提供数据驱动的预测、监管考虑和竞争情报，帮助相关人员应对不断变化的数位病理学解决方案格局。

调查概述

本报告按产品类型（扫描器、软体、资讯管理系统、储存和云端解决方案、通讯和网路系统）、最终用户（医院、诊断实验室、製药和生物技术公司、学术和研究机构、受託研究机构）、应用（药物发现和开发、疾病诊断、学术研究、远距病理学、培训和教育）和地区市场（北美、南美、欧洲、中东和非洲、亚太地区）研究全球数位病理市场（北美、南美、欧洲、中东和非洲、亚太地区）。除了包括波特五力分析、产业价值链分析和市场占有率评估在内的强大分析之外，该报告还包括策略建议和监管见解，以帮助相关人员利用成长机会。它强调了关键驱动因素，例如病理学中人工智慧的应用和对远距离诊断的需求，以及挑战，例如高实施成本和监管复杂性。

竞争格局与分析

数位病理学市场研究的竞争情报部分强调了主要企业为提升其市场占有率而采取的策略性倡议。例如，徕卡生物系统公司 Nussloch GmbH（丹纳赫）于 2024 年推出了其 Aperio GT 450 DX 扫描仪的升级版，增强了人工智慧主导的影像分析功能，以便美国各地的诊断实验室更快诊断疾病。这项发展加强了徕卡生物系统在高通量扫描解决方案方面的领导地位。同样，荷兰皇家飞利浦公司于 2025 年透过与欧洲领先的医院网路建立策略合作伙伴关係扩展了其数位病理学产品组合，并将其 IntelliSite 平台与云端基础的储存解决方案相结合，以增强德国和法国的远端病理学服务。该研究还包括市场占有率分析、併购以及提供竞争格局整体情况的竞争仪表板。

结论

这份研究报告是业界专业人士了解数位病理学市场复杂性的必备资源。透过提供详细的细分市场、技术格局和竞争情报，本研究为识别机会和製定有效策略提供了坚实的框架。徕卡生物系统公司（Leica Biosystems Nussloch GmbH）和荷兰皇家飞利浦公司（Koninklijke Philips NV）等领先公司正在推动人工智慧扫描和云端整合远端病理学解决方案的技术创新，数位病理学市场的竞争正帮助相关人员在这个充满活力且快速发展的行业中保持竞争力。

本报告的主要优点

  • 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分领域。
  • 竞争格局：了解主要企业正在采取的策略倡议，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来提供策略决策，在动态环境中开闢新的业务流和收益。
  • 受众范围广：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具成本效益的。

报告的主要用途

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022-2024年实际数据及2025-2030年预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 各地区（包括细分市场和国家）的收益成长和预测分析
  • 公司简介（主要包括策略、产品、财务资讯、主要发展动态等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章数位病理学市场（按产品类型）

  • 介绍
  • 扫描器
  • 软体
  • 资讯管理系统
  • 储存和云端解决方案
  • 通讯与网路系统

第六章：数位病理学市场（按最终用户）

  • 介绍
  • 医院
  • 诊断实验室
  • 製药和生物技术公司
  • 学术和研究机构
  • 受託研究机构（CRO）

第七章数位病理学市场（按应用）

  • 介绍
  • 药物发现与开发
  • 疾病诊断
  • 学术研究
  • 远端病理学
  • 培训和教育

第 8 章：按地区分類的数位病理学市场

  • 介绍
  • 北美洲
    • 依产品类型
    • 按最终用户
    • 按用途
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型
    • 按最终用户
    • 按用途
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型
    • 按最终用户
    • 按用途
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依产品类型
    • 按最终用户
    • 按用途
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依产品类型
    • 按最终用户
    • 按用途
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章：竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 併购、协议和合作
  • 竞争对手仪表板

第十章：公司简介

  • Leica Biosystems Nussloch GmbH（Danaher）
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips NV
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies, Inc.
  • Epredia（3DHISTECH Ltd.）
  • Visiopharm A/S
  • Huron Technologies International Inc.
  • ContextVision AB

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061610505

The Digital Pathology Market is expected to grow from USD 1,078.255 million in 2025 to USD 2,305.011 million in 2030, at a CAGR of 16.41%.

The Digital Pathology Market Study delivers a comprehensive analysis of the global digital pathology market, providing industry experts with critical insights into market trends, technological advancements, and competitive strategies shaping this transformative healthcare sector. This study explores key market dynamics, including drivers, restraints, and opportunities, with detailed segmentation by product type, end-user, application, and geography. Designed to support strategic decision-making, the Digital Pathology Market Study equips stakeholders with data-driven forecasts, regulatory insights, and competitive intelligence to navigate the evolving landscape of digital pathology solutions.

Study Overview

The Digital Pathology Market Study examines the global digital pathology market, segmented by product type (Scanners, Software, Information Management Systems, Storage & Cloud Solutions, Communication & Networking Systems), end-user (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), application (Drug Discovery and Development, Disease Diagnosis, Academic Research, Telepathology, Training & Education), and geography (North America, South America, Europe, Middle East and Africa, Asia Pacific). It includes robust analyses such as Porter's Five Forces Analysis, Industry Value Chain Analysis, and market share evaluations, alongside strategic recommendations and regulatory insights to help stakeholders capitalize on growth opportunities. The study highlights key driving factors, such as the adoption of AI in pathology and demand for remote diagnostics, and challenges, including high implementation costs and regulatory complexities.

Competitive Environment and Analysis

In the competitive intelligence section of the Digital Pathology Market Study, key players are highlighted for their strategic initiatives to strengthen market presence. For instance, Leica Biosystems Nussloch GmbH (Danaher) launched an upgraded version of its Aperio GT 450 DX scanner in 2024, featuring enhanced AI-driven image analysis for faster disease diagnosis in diagnostic laboratories across the United States. This development reinforces Leica Biosystems' leadership in high-throughput scanning solutions. Similarly, Koninklijke Philips N.V. expanded its digital pathology portfolio through a 2025 strategic collaboration with a leading European hospital network, integrating its IntelliSite platform with cloud-based storage solutions to enhance telepathology services in Germany and France. The study also includes market share analysis, mergers, acquisitions, and a competitive dashboard to provide a holistic view of the competitive landscape.

Conclusion

The Digital Pathology Market Study is an essential resource for industry experts seeking to understand the complexities of the digital pathology market. By offering detailed segmentation, technological outlooks, and competitive intelligence, this study provides a robust framework for identifying opportunities and formulating effective strategies. With leading players like Leica Biosystems Nussloch GmbH and Koninklijke Philips N.V. driving innovation in AI-enhanced scanning and cloud-integrated telepathology solutions, the Digital Pathology Market Study empowers stakeholders to stay competitive in this dynamic and rapidly growing industry.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Different segments covered under the digital pathology market report are as below:

By Product Type

  • Scanners
  • Software
  • Information Management Systems
  • Storage & Cloud Solutions
  • Communication & Networking Systems

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Application

  • Drug Discovery and Development
  • Disease Diagnosis
  • Academic Research
  • Telepathology
  • Training & Education

By Geography

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. DIGITAL PATHOLOGY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Scanners
  • 5.3. Software
  • 5.4. Information Management Systems
  • 5.5. Storage & Cloud Solutions
  • 5.6. Communication & Networking Systems

6. DIGITAL PATHOLOGY MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Diagnostic Laboratories
  • 6.4. Pharmaceutical & Biotechnology Companies
  • 6.5. Academic & Research Institutes
  • 6.6. Contract Research Organizations (CROs)

7. DIGITAL PATHOLOGY MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Drug Discovery and Development
  • 7.3. Disease Diagnosis
  • 7.4. Academic Research
  • 7.5. Telepathology
  • 7.6. Training & Education

8. DIGITAL PATHOLOGY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By End-User
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By End-User
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By End-User
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By End-User
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By End-User
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Leica Biosystems Nussloch GmbH (Danaher)
  • 10.2. Hamamatsu Photonics, Inc.
  • 10.3. Koninklijke Philips N.V.
  • 10.4. Olympus Corporation
  • 10.5. F. Hoffmann-La Roche Ltd.
  • 10.6. Mikroscan Technologies, Inc.
  • 10.7. Epredia (3DHISTECH Ltd.)
  • 10.8. Visiopharm A/S
  • 10.9. Huron Technologies International Inc.
  • 10.10. ContextVision AB

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations